Abstract
Over the last decade, new topical and systemic antimycotics (imidazole derivatives, triazoles, allylamines, and morpholine derivatives) have come onto the market. They have increased therapeutic possibilities, even though these new drugs are not yet available in every country. A standard treatment that will lead to cure in all cases is not available as yet. Therefore, treatment must take into account a number of factors in order to be successful in the long term.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
